AGF Investments Inc’s Evolent Health EVH Stock Holding History

AGF Investments Inc’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-125,000	Closed	-$2.23M	–	381
2017 Q3	$2.23M	Buy	+125,000	New	+$2.58M	0.02%	246

Other funds holding EVH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Formula Growth Montreal, Quebec, Canada $222M AUM 27.84% 1-Year Est. Return

AGF Investments Inc's EVH Position: Q4 2017 in Review

AGF Investments Inc sold out of Evolent Health (EVH) in Q4 2017, closing a stake of 125,000 shares — an estimated $2.23M sold.

AGF Investments Inc first reported a position in EVH in Q3 2017 and held it in 1 quarter. The position peaked at $2.23M in Q3 2017. 156 funds tracked by Wall St. Rank hold EVH as of Q4 2017.

AGF Investments Inc reported no remaining Evolent Health position as of Q4 2017 after selling out during the quarter.
AGF Investments Inc sold 125,000 Evolent Health shares in Q4 2017, an estimated $2.23M.
AGF Investments Inc first reported a position in Evolent Health in Q3 2017 and held it in 1 quarter.
AGF Investments Inc's Evolent Health position peaked at $2.23M in Q3 2017.
156 funds tracked by Wall St. Rank held Evolent Health as of Q4 2017.

Based on AGF Investments Inc's 13F filing for Q4 2017, filed 7 Feb 2018.